Life Sciences 4.0: The EU AI Act unfolded

Join us for our event series on the EU AI Act and how it applies to the life sciences industry.

The EU AI Act has arrived and will have implications not only for AI-based medical devices, but for many other uses of AI in the life cycle of pharmaceutical products, medical devices and other digital health services.

Register now for our webinars to learn more about opportunities and challenges that medtech, pharma and digital health companies need to be aware of.


EU AI Act: a new era for AI

8 October 2024 - Webinar (Zoom)

In our first webinar we will explore:

  • Applicability of AI Act - classification of AI systems, examples of low/medium/high risk systems
  • Similarities and differences between MDR and AI Act
  • Economic operators and supply chain

Speakers: Arne Thiermann, Fabien Roy, Hélène Boland

Navigating the AI Act: risks, regulations, and opportunities

3 December 2024 - Webinar (Zoom)

During the second webinar we will discuss:

  • Real-world testing, sandboxes, research exemption and clinical investigations
  • Implications of the EU AI Act for pharma companies
  • Company-adapted GPTs and other AI solutions

Speakers: Arne Thiermann, Fabien Roy, Jörg Schickert, Hannah Wiborg

If you would like to join us, register here.


Back To Listing